ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024
18 JUNE 2024
NORTHERN 3 VCT PLC
ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH
2024
Northern 3 VCT PLC is a Venture Capital Trust (VCT) managed by
Mercia Fund Management Limited. It invests mainly in unquoted
venture capital holdings and aims to provide long-term tax-free
returns to shareholders through a combination of dividend yield and
capital growth.
Financial highlights (comparative figures
as at 31 March 2023):
|
|
Year ended |
Year ended |
|
|
31 March |
31 March |
|
|
2024 |
2023 |
|
|
|
|
Net assets |
|
£122.5m |
£113.0m |
|
|
|
|
Net asset value per share |
|
89.3p |
91.6p |
|
|
|
|
Return per share |
|
|
|
Revenue |
|
1.1p |
(0.1)p |
Capital |
|
1.1p |
(1.5)p |
Total |
|
2.2p |
(1.6)p |
|
|
|
|
Dividend per share declared in respect of the
period |
|
|
|
Interim dividend |
|
2.0p |
2.0p |
Proposed final dividend |
|
2.2p |
2.5p |
Total |
|
4.2p |
4.5p |
|
|
|
|
Return to shareholders since launch |
|
|
|
Net asset value per share |
|
89.3p |
91.6p |
Cumulative dividends paid per
share* |
|
117.9p |
113.4p |
Cumulative return per share |
|
207.2p |
205.0p |
|
|
|
|
Mid-market share price at end of period |
|
84.5p |
84.5p |
|
|
|
|
Share price discount to net asset value |
|
5.4% |
7.8% |
|
|
|
|
Annualised tax-free dividend yield** |
4.6% |
4.6% |
* Excluding proposed final dividend payable on 23 August
2024
** Based on net asset value per share at the start of the
period
Enquiries:
James Sly / Sarah Williams, Mercia Asset Management PLC – 0330 223
1430
Website: www.mercia.co.uk/vcts/n3vct/
Chairman’s statement
Results and dividend
The net asset value (NAV) per share at 31 March 2024 was 89.3 pence
compared with 91.6 pence as at 31 March 2023. The total return per
share for the year as shown in the income statement was 2.2 pence
(2023: minus 1.6 pence).
The target annual dividend yield continues to be set at 4.5% of
opening NAV per share. Having already declared an interim dividend
of 2.0 pence per share which was paid in January 2024, the
Directors now propose a final dividend of 2.2 pence. These payments
totalling 4.2 pence (2023 : 4.5 pence) are equivalent to 4.6% of
the opening NAV (2023: 4.6%). The proposed final dividend will,
subject to approval by shareholders at the Annual General Meeting,
be paid on 23 August 2024.
Our dividend investment scheme, under which dividends can be
re-invested in new ordinary shares free of dealing costs and with
the benefit of the tax reliefs available on new VCT share
subscriptions, continues to operate. Instructions on how to join
the scheme are included within the dividend section of our website,
which can be found here:
mercia.co.uk/vcts/n3vct/.
Investment portfolio
A number of notable transactions were either completed or in
progress as of 31 March 2024. The highlight during the year was the
sale of Evotix (formerly SHE Software) which provided an initial
return of 4.6 times cost rising to 4.9 times following the recent
receipt of further deferred income since the year end, included in
this set of results.
Several portfolio companies enjoyed significant growth in the
year – Pure Pet Food, Project Glow Topco (t/a Currentbody.com) and
Pimberly each increased in value by over £1 million. Sales in the
venture portfolio realised £13.1 million on an initial cost of £8.0
million, producing a gain of £5.1 million. Against this provisions
were raised in the investments in Volumatic Holdings and Grip UK
(t/a Climbing Hangar). Additionally the value of musicMagpie, which
is listed on AIM, fell by £0.7 million. £7.5 million was provided
for six new venture capital investments and £7.6 million of follow
on capital was invested in existing investments.
There have been recent comments suggesting that in general
unlisted shares have been valued too highly. We would like to
reiterate the fact that your Board has always had a realistic but
conservative approach to valuation policy, which is reflected in
our net asset value.
Share offers and liquidity
In April 2023 gross proceeds of £6.0 million were received from the
2022/2023 share offer with 6,597,040 new ordinary shares issued. We
announced recently the successful subscription of the 2023/2024
share offer, which amounted to £20 million of gross subscriptions.
This was made up of an interim allotment of 9,681,062 new ordinary
shares in December 2023, generating £9.0 million in gross
subscriptions, and 11,702,332 new ordinary shares issued just after
the end of the period in April 2024, yielding gross subscriptions
of £11.0 million.
The Board continues to monitor liquidity carefully and will
publish details of the plans for raising funds in the 2024/25 tax
year in due course.
We have maintained our policy of buying back our shares in the
market, where necessary to maintain market liquidity. During the
year 3,255,224 shares, equivalent to approximately 2.6% of the
opening share capital, were purchased for cancellation.
Responsible Investment
The Company’s approach to Environmental, Social and Governance
(ESG) responsibilities is set out in the annual report.
Succession planning
Following a change of Manager in 2019, the impact of COVID, and the
geopolitical and macroeconomic issues that I have discussed in my
previous statements, the Nomination Committee has prioritised Board
stability during the last few years. The Committee feels that it is
now appropriate to progress its succession plan and the Board
anticipates that an additional director will be appointed in the
current financial period.
VCT legislation and qualifying status
The Company has continued to meet the stringent and complex
qualifying conditions laid down by HM Revenue & Customs for
maintaining its approval as a VCT. The Manager reports regularly on
the position to the Board. Philip Hare & Associates LLP has
continued to act as independent adviser to the Company on VCT
taxation matters.
The Board was pleased to note the recognition by the UK
Government of the role that VCTs perform, following the
announcement of the extension of the VCT tax reliefs for a further
10 years to 2035. The Board considers that the Company is
delivering in accordance with the Government’s mandate, which is to
channel money into higher-risk, early-stage businesses.
Whilst no further amendments to the VCT legislation have been
announced, it is possible that further changes will be made in the
future. We will continue to work closely with the Manager to
maintain compliance with the scheme rules at all times.
Annual General Meeting
The Company’s Annual General Meeting (AGM) will take place on 1
August 2024. We intend to hold the 2024 AGM in person at Shoosmiths
LLP, 9 Haymarket Square, Edinburgh, EH3 8RY. Following positive
comments received from the last meetings, we also intend to offer
remote access for shareholders through an online webinar facility.
Full details and formal notice of the AGM will be provided
separately. Please note that shareholders attending remotely must
register their votes ahead of time, as it will not be possible to
count votes from online participants at the AGM.
Outlook
Access to capital is one of the key factors contributing to the
success of early stage businesses; we are confident that the
Company is well-positioned to provide this. Despite economic
uncertainties, we are encouraged by the present opportunities for
investment.
James Ferguson
Chairman
18 June 2024
Extracts from the audited financial statements
for the year ended 31 March 2024 are set out below:
Income statement
for the year ended 31
March 2024 |
Year ended 31 March 2024 |
|
Year ended 31 March 2023 |
|
Revenue |
Capital |
Total |
|
Revenue |
Capital |
Total |
|
£000 |
£000 |
£000 |
|
£000 |
£000 |
£000 |
|
|
|
|
|
|
|
|
Gain on disposal of
investments |
- |
855 |
855 |
|
- |
1,414 |
1,414 |
Movement in fair value of investments |
- |
2,312 |
2,312 |
|
- |
(1,540) |
(1,540) |
|
- |
3,167 |
3,167 |
|
- |
(126) |
(126) |
|
|
|
|
|
|
|
|
Dividend and interest
income |
2,590 |
- |
2,590 |
|
732 |
- |
732 |
Investment management fee |
(528) |
(1,585) |
(2,113) |
|
(519) |
(1,558) |
(2,077) |
Other
expenses |
(606) |
- |
(606) |
|
(496) |
- |
(496) |
|
|
|
|
|
|
|
|
Return before
tax |
1,456 |
1,582 |
3,038 |
|
(283) |
(1,684) |
(1,967) |
|
|
|
|
|
|
|
|
Tax on
return |
82 |
(82) |
- |
|
122 |
(122) |
- |
|
|
|
|
|
|
|
|
Return after tax |
1,538 |
1,500 |
3,038 |
|
(161) |
(1,806) |
(1,967) |
|
|
|
|
|
|
|
|
Return per share |
1.1p |
1.1p |
2.2p |
|
(0.1)p |
(1.5)p |
(1.6)p |
Balance sheet
as at 31 March
2024 |
|
31 March 2024 |
31 March 2023 |
|
|
£000 |
£000 |
|
|
|
|
Fixed
assets |
|
|
|
Investments |
|
91,001 |
85,775 |
|
|
|
|
Current
assets |
|
|
|
Debtors |
|
927 |
107 |
Cash
and cash equivalents |
|
30,726 |
27,280 |
|
|
31,653 |
27,387 |
|
|
|
|
Creditors (amounts falling due within one
year) |
|
(158) |
(169) |
|
|
|
|
Net current assets |
|
31,495 |
27,218 |
|
|
|
|
Net assets |
|
122,496 |
112,993 |
|
|
|
|
Capital and
reserves |
|
|
|
Called-up equity share
capital |
|
6,858 |
6,166 |
Share premium |
|
51,738 |
37,344 |
Capital redemption
reserve |
|
934 |
771 |
Capital reserve |
|
58,846 |
63,561 |
Revaluation reserve |
|
2,674 |
4,554 |
Revenue
reserve |
|
1,446 |
597 |
|
|
|
|
Total equity shareholders' funds |
|
122,496 |
112,993 |
|
|
|
|
Net asset value per share |
|
89.3p |
91.6p |
Statement of changes in equity
for the year ended 31
March 2024 |
|
|
|
|
|
|
|
|
--------------- |
Non-distributable reserves |
----------- |
Distributable reserves |
|
|
Called up share capital |
Share premium |
Capital redemption reserve |
Revaluation reserve |
Capital reserve |
Revenue reserve |
Total |
|
£000 |
£000 |
£000 |
£000 |
£000 |
£000 |
£000 |
At 1 April 2023 |
6,166 |
37,344 |
771 |
4,554 |
63,561 |
597 |
112,993 |
Return after tax |
- |
- |
- |
(1,880) |
3,380 |
1,538 |
3,038 |
Dividends paid |
- |
- |
- |
- |
(5,295) |
(689) |
(5,984) |
Net proceeds of share
issues |
855 |
14,394 |
- |
- |
- |
- |
15,249 |
Shares purchased for
cancellation |
(163) |
- |
163 |
- |
(2,800) |
- |
(2,800) |
|
|
|
|
|
|
|
|
At 31 March 2024 |
6,858 |
51,738 |
934 |
2,674 |
58,846 |
1,446 |
122,496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
for the year ended 31
March 2023 |
--------------- |
Non-distributable reserves |
-------------- |
Distributable reserves |
|
|
Called up share capital |
Share premium |
Capital redemption reserve |
Revaluation reserve |
Capital reserve |
Revenue reserve |
Total |
|
£000 |
£000 |
£000 |
£000 |
£000 |
£000 |
£000 |
At 1 April 2022 |
5,456 |
20,909 |
602 |
13,659 |
64,849 |
1,385 |
106,860 |
Return after tax |
- |
- |
- |
(9,105) |
7,299 |
(161) |
(1,967) |
Dividends paid |
- |
- |
- |
- |
(5,614) |
(627) |
(6,241) |
Net proceeds of share
issues |
879 |
16,435 |
- |
- |
- |
- |
17,314 |
Shares purchased for
cancellation |
(169) |
- |
169 |
- |
(2,973) |
- |
(2,973) |
|
|
|
|
|
|
|
|
At 31 March 2023 |
6,166 |
37,344 |
771 |
4,554 |
63,561 |
597 |
112,993 |
Statement of cash flows
for the year ended 31
March 2024 |
Year ended |
|
Year ended |
|
31 March 2024 |
|
31 March 2023 |
|
£000 |
|
£000 |
Cash flows from
operating activities |
|
|
|
Return before tax |
3,038 |
|
(1,967) |
Adjustments for: |
|
|
|
(Gain) / loss on disposal of
investments |
(855) |
|
(1,414) |
Movements in fair value of
investments |
(2,312) |
|
1,540 |
(Increase) / decrease in
debtors |
(122) |
|
(47) |
Increase / (decrease) in
creditors |
(11) |
|
17 |
Net cash inflow / (outflow) from operating
activities |
(262) |
|
(1,871) |
|
|
|
|
Cash flows from
investing activities |
|
|
|
Purchase of investments |
(17,614) |
|
(17,699) |
Sale / repayment of
investments |
14,857 |
|
17,067 |
Net cash inflow / (outflow) from investing
activities |
(2,757) |
|
(632) |
|
|
|
|
Cash flows from
financing activities |
|
|
|
Issue of ordinary shares |
15,784 |
|
17,815 |
Share issue expenses |
(535) |
|
(501) |
Purchase of ordinary shares
for cancellation |
(2,800) |
|
(2,973) |
Equity dividends paid |
(5,984) |
|
(6,241) |
Net cash inflow / (outflow) from financing
activities |
6,465 |
|
8,100 |
|
|
|
|
Increase / (decrease)
in cash and cash equivalents |
3,446 |
|
5,597 |
Cash
and cash equivalents at beginning of year |
27,280 |
|
21,683 |
Cash and cash equivalents at end of year |
30,726 |
|
27,280 |
Investment portfolio
as at 31 March 2024
|
|
Cost |
Valuation |
Like for like valuation increase/ (decrease) over
year** |
% of net assets |
|
|
£000 |
£000 |
£000 |
by value |
Fifteen largest venture capital investments |
|
|
|
1 |
Pimberly |
1,910 |
3,227 |
1,317 |
2.6% |
2 |
Project Glow Topco (t / a
Currentbody.com) |
1,519 |
3,206 |
1,686 |
2.6% |
3 |
Tutora (t / a Tutorful) |
2,973 |
2,973 |
(103) |
2.4% |
4 |
Newcells Biotech |
2,707 |
2,928 |
185 |
2.4% |
5 |
Pure Pet Food |
1,601 |
2,897 |
1,232 |
2.4% |
6 |
Rockar |
1,660 |
2,800 |
328 |
2.3% |
7 |
IDOX* |
530 |
2,684 |
(44) |
2.2% |
8 |
Netacea |
2,577 |
2,577 |
– |
2.1% |
9 |
Gentronix |
805 |
2,532 |
727 |
2.1% |
10 |
Adludio |
2,438 |
2,447 |
9 |
2.0% |
11 |
Grip-UK (t / a The Climbing
Hangar) |
3,492 |
2,343 |
(1,149) |
1.9% |
12 |
Broker Insights |
2,032 |
2,041 |
9 |
1.7% |
13 |
Buoyant Upholstery |
907 |
1,985 |
521 |
1.6% |
14 |
Ridge Pharma |
1,345 |
1,947 |
600 |
1.6% |
15 |
Volumatic Holdings |
216 |
1,921 |
(1,354) |
1.6% |
Other venture capital investments |
|
|
|
|
16 |
LMC Software |
1,909 |
1,909 |
– |
1.6% |
17 |
Forensic Analytics |
1,869 |
1,869 |
– |
1.5% |
18 |
Clarilis |
1,772 |
1,772 |
– |
1.4% |
19 |
Biological Preparations
Group |
1,915 |
1,746 |
(74) |
1.4% |
20 |
Turbine Simulated Cell
Technologies |
1,542 |
1,744 |
202 |
1.4% |
21 |
Camena Bioscience |
1,744 |
1,744 |
– |
1.4% |
22 |
Social Value Portal |
1,722 |
1,722 |
– |
1.4% |
23 |
Locate Bio |
1,625 |
1,625 |
– |
1.3% |
24 |
Risk Ledger |
1,556 |
1,556 |
– |
1.3% |
25 |
VoxPopMe |
1,493 |
1,493 |
12 |
1.2% |
26 |
Enate |
1,373 |
1,373 |
– |
1.1% |
27 |
Administrate |
2,143 |
1,349 |
(366) |
1.1% |
28 |
Optellum |
1,250 |
1,250 |
– |
1.0% |
29 |
Moonshot |
1,217 |
1,217 |
– |
1.0% |
30 |
Centuro Global |
1,136 |
1,136 |
– |
0.9% |
31 |
MIP Discovery |
1,115 |
1,115 |
– |
0.9% |
32 |
Wobble Genomics |
1,053 |
1,053 |
– |
0.9% |
33 |
Send Technology Solutions |
1,049 |
1,049 |
– |
0.9% |
34 |
iOpt |
1,038 |
1,038 |
– |
0.8% |
35 |
Wonderush Ltd (t / a Hownow) |
1,029 |
1,029 |
– |
0.8% |
36 |
Axis Spine Technologies |
1,028 |
1,028 |
– |
0.8% |
37 |
Warwick Acoustics |
1,019 |
1,019 |
– |
0.8% |
38 |
Seahawk Bidco |
433 |
838 |
444 |
0.7% |
39 |
Naitive Technologies |
721 |
721 |
– |
0.6% |
40 |
Oddbox |
986 |
718 |
41 |
0.6% |
41 |
Northrow |
1,385 |
638 |
(100) |
0.5% |
42 |
Eckoh* |
528 |
629 |
34 |
0.5% |
43 |
Duke & Dexter |
1,113 |
580 |
(541) |
0.5% |
44 |
Intuitive Holding |
1,293 |
573 |
43 |
0.5% |
45 |
Rego Technologies (t / a
Upp)(formerly Volo) |
2,182 |
522 |
91 |
0.4% |
46 |
Synthesized |
500 |
500 |
– |
0.4% |
47 |
Netcall* |
273 |
450 |
(40) |
0.4% |
48 |
Fresh Approach (UK) Holdings |
805 |
417 |
(331) |
0.4% |
49 |
Thanksbox (t / a Mo) |
1,520 |
374 |
(207) |
0.3% |
50 |
Atlas Cloud |
638 |
351 |
(287) |
0.3% |
51 |
Sen Corporation |
666 |
293 |
(376) |
0.3% |
52 |
musicMagpie* |
201 |
255 |
(683) |
0.2% |
53 |
Arnlea Holdings |
1,138 |
207 |
10 |
0.2% |
54 |
ECO Animal Health* |
497 |
191 |
(28) |
0.2% |
55 |
Sorted |
154 |
154 |
(25) |
0.1% |
56 |
Synectics* |
171 |
146 |
49 |
0.1% |
57 |
Pebble Beach Systems* |
564 |
100 |
30 |
0.1% |
58 |
Customs Connect Group |
1,348 |
100 |
(8) |
0.1% |
59 |
Angle* |
131 |
45 |
(28) |
0.0% |
60 |
Velocity Composites* |
57 |
20 |
(1) |
0.0% |
61 |
Quotevine |
1,184 |
– |
– |
0.0% |
62 |
Nutshell |
665 |
– |
(349) |
0.0% |
63 |
Ablatus Therapeutics |
551 |
– |
– |
0.0% |
Total venture capital investments |
78,013 |
78,166 |
|
63.8% |
Listed equity investments |
10,314 |
12,835 |
|
10.5% |
Total fixed asset investments |
88,327 |
91,001 |
|
74.3% |
Net current assets |
|
31,495 |
|
25.7% |
Net assets |
|
122,496 |
|
100.0% |
* Quoted on AIM
**This change in ‘like for like’ valuations is a comparison of the
31 March 2024 valuations with the 31 March 2023 valuations (or
where a new investment has been made in the year, the investment
amount), having adjusted for any partial disposals, loan stock
repayments or new and follow-on investments in the year.
Risk management
The Board carries out a regular and robust assessment of the risk
environment in which the Company operates and seeks to identify new
risks as they emerge. The principal and emerging risks and
uncertainties identified by the Board which might affect the
Company’s business model and future performance, and the steps
taken with a view to their mitigation, are as follows:
Investment and liquidity risk: investment in
smaller and unquoted companies, such as those in which the Company
invests, involves a higher degree of risk than investment in larger
listed companies because they generally have limited product lines,
markets and financial resources and may be more dependent on key
individuals. The securities of smaller companies in which the
Company invests are typically unlisted, making them illiquid, and
this may cause difficulties in valuing and disposing of the
securities. The Company may invest in businesses whose shares are
quoted on AIM – the fact that a share is quoted on AIM does not
mean that it can be readily traded and the spread between the
buying and selling prices of such shares may be wide.
Mitigation: the Directors aim to limit the risk
attaching to the portfolio as a whole by careful selection, close
monitoring and timely realisation of investments, by carrying out
rigorous due diligence procedures and maintaining a wide spread of
holdings in terms of financing stage and industry sector, within
the rules of the VCT scheme. The Board reviews the investment
portfolio with the Manager on a regular basis.
Financial risk: most of the Company’s
investments involve a medium to long-term commitment and many are
illiquid.
Mitigation: the Directors consider that it is
inappropriate to finance the Company’s activities through borrowing
except on an occasional short-term basis. Accordingly they seek to
maintain a proportion of the Company’s assets in cash or cash
equivalents in order to be in a position to pursue new unquoted
investment opportunities and to make follow-on investments in
existing portfolio companies. The Company has very little direct
exposure to foreign currency risk and does not enter into
derivative transactions.
Economic risk: events such as economic
recession or general fluctuation in stock markets, exchange rates
and interest rates may affect the valuation of investee companies
and their ability to access adequate financial resources, as well
as affecting the Company’s own share price and discount to net
asset value. The level of economic risk has been elevated recently
by inflationary pressures, interest rate increases, and supply
shortages.
Mitigation: the Company invests in a
diversified portfolio of investments spanning various industry
sectors, and maintains sufficient cash reserves to be able to
provide additional funding to investee companies where it is
appropriate and in the interests of the Company to do so. The
Manager typically provides an investment executive to actively
support the board of each unquoted investee company. At all times,
and particularly during periods of heightened economic uncertainty,
the investment executives share best practice from across the
portfolio with investee management teams in order to mitigate
economic risk.
Stock market risk: some of the Company’s
investments are quoted on the London Stock Exchange or AIM and will
be subject to market fluctuations upwards and downwards. External
factors such as the terrorist activity, political activity or
global health crises can negatively impact stock markets worldwide.
In times of adverse sentiment there may be very little, if any,
market demand for shares in smaller companies quoted on AIM.
Mitigation: the Company’s quoted investments
are actively managed by specialist managers, including Mercia in
the case of the AIM-quoted investments, and the Board keeps the
portfolio and the actions taken under ongoing review.
Credit risk: the Company holds a number of
financial instruments and cash deposits and is dependent on the
counterparties discharging their commitment.
Mitigation: the Directors review the
creditworthiness of the counterparties to these instruments and
cash deposits and seek to ensure there is no undue concentration of
credit risk with any one party.
Legislative and regulatory risk: in order to
maintain its approval as a VCT, the Company is required to comply
with current VCT legislation in the UK. Changes to the UK
legislation in the future could have an adverse effect on the
Company’s ability to achieve satisfactory investment returns whilst
retaining its VCT approval.
Mitigation: the Board and the Manager monitor
political developments and where appropriate seek to make
representations either directly or through relevant trade
bodies.
Internal control risk: the Company’s assets
could be at risk in the absence of an appropriate internal control
regime which is able to operate effectively even during times of
disruption.
Mitigation: the Board regularly reviews the
system of internal controls, both financial and non-financial,
operated by the Company and the Manager. These include controls
designed to ensure that the Company’s assets are safeguarded and
that proper accounting records are maintained.
VCT qualifying status risk: while it is the
intention of the Directors that the Company will be managed so as
to continue to qualify as a VCT, there can be no guarantee that
this status will be maintained. A failure to continue meeting the
qualifying requirements could result in the loss of VCT tax relief,
the Company losing its exemption from corporation tax on capital
gains, to shareholders being liable to pay income tax on dividends
received from the Company and, in certain circumstances, to
shareholders being required to repay the initial income tax relief
on their investment.
Mitigation: the Manager keeps the Company’s VCT
qualifying status under continual review and its reports are
reviewed by the Board on a quarterly basis. The Board has also
retained Philip Hare & Associates LLP to undertake an
independent VCT status monitoring role.
The Board continually assesses and monitors emerging risks that
could impact the Company's operations and strategic objectives. As
part of the risk assessment process, the Board evaluates a wide
range of potential threats and uncertainties that may arise from
evolving market dynamics, regulatory changes, technological
advancements, geopolitical developments, and other external
factors. By remaining aware of emerging risks, the Board ensures
that the Company is better equipped to anticipate challenges and
adapt swiftly to changing circumstances.
Directors’ Responsibilities
The Directors are responsible for preparing the annual report and
financial statements in accordance with applicable law and
regulations.
Company law requires the Directors to prepare financial
statements for each financial year. Under that law they are
required to prepare the financial statements in accordance with UK
accounting standards, including FRS 102 ‘The Financial Reporting
Standard applicable in the UK and Republic of Ireland’.
Under company law the Directors must not approve the financial
statements unless they are satisfied that they give a true and fair
view of the state of affairs of the Company and of its profit or
loss for the year.
In preparing these financial statements, the Directors are
required to:
- select suitable accounting
policies and then apply them consistently;
- make judgements and estimates
that are reasonable and prudent;
- state whether applicable UK
accounting standards have been followed, subject to any material
departures disclosed and explained in the financial
statements;
- assess the Company’s ability to
continue as a going concern, disclosing, as applicable, matters
related to going concern; and
- use the going concern basis of
accounting unless they either intend to liquidate the Company or to
cease operations, or have no realistic alternative but to do
so.
The Directors are responsible for keeping adequate accounting
records that are sufficient to show and explain the Company’s
transactions and disclose with reasonable accuracy at any time the
financial position of the Company and enable them to ensure that
its financial statements comply with the Companies Act 2006. They
are responsible for such internal control as they determine is
necessary to enable the preparation of financial statements that
are free from material misstatement, whether due to fraud or error,
and have general responsibility for taking such steps as are
reasonably open to them to safeguard the assets of the Company and
to prevent and detect fraud and other irregularities.
Under applicable law and regulations, the Directors are also
responsible for preparing a Strategic Report, Directors’ Report,
Directors’ Remuneration Report and corporate governance statement
that complies with that law and those regulations.
The Directors are responsible for the maintenance and integrity
of the corporate and financial information included on the
Company’s website. Legislation in the UK governing the preparation
and dissemination of financial statements may differ from
legislation in other jurisdictions.
The Directors confirm that to the best of their knowledge:
- the financial statements,
prepared in accordance with the applicable set of accounting
standards, give a true and fair view of the assets, liabilities,
financial position and profit or loss of the Company; and
- the Strategic Report and
Directors’ Report includes a fair review of the development and
performance of the business and the position of the issuer,
together with a description of the principal risks and
uncertainties that they face.
The Directors consider the annual report and accounts, taken as
a whole, is fair, balanced and understandable and provides the
information necessary for shareholders to assess the Company’s
position and performance, business model and strategy.
The Directors of the company at the date of this announcement were
Mr J G D Ferguson (Chairman), Mrs A B Brown, Mr C J Fleetwood,
Mr T R Levett and Mr J M O Waddell.
Other matters
The financial information set out above does not constitute the
company’s statutory accounts for the years ended 31 March 2024 or
2023 but is derived from those accounts. Statutory accounts for
2023 have been delivered to the registrar of companies, and those
for 2024 will be delivered in due course. The auditor has reported
on those accounts; their reports were (i) unqualified; (ii) did not
include a reference to any matters to which the auditor drew
attention by way of emphasis without qualifying their report; and
(iii) did not contain a statement under section 498 (2) or (3) of
the Companies Act 2006.
The calculation of the return per share is based on the return
after tax for the year of £3,038,000 (2023: loss £1,967,0000) and
on 131,811,967 (2023: 124,886,897) shares, being the weighted
average number of shares in issue during the year.
The calculation of net asset value per share as at 31 March 2024
is based on net assets of £122,496,000 (2023: £112,993,000) divided
by the 137,164,335 (2023: 123,319,779) ordinary shares in issue
at
that date.
If approved by shareholders, the proposed final dividend of 2.2
pence per share for the year ended 31 March 2024 will be paid on 23
August 2024 to shareholders on the register at the close of
business on 26 July 2024.
The full annual report including financial statements for the
year ended 31 March 2024 is expected to be made available to
shareholders on or around 28 June 2024 and will be available to the
public at the registered office of the company at Forward House, 17
High Street, Henley-in-Arden B95 5AA and on the company’s
website.
Neither the contents of the Mercia Asset Management PLC website,
nor the contents of any website accessible from hyperlinks on the
Mercia Asset Management PLC website (or any other website), are
incorporated into, or form part of, this announcement.
Northern 3 Vct (LSE:NTN)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Northern 3 Vct (LSE:NTN)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024